Development of an affinity silica monolith containing human serum albumin for chiral separations

Rangan Mallik, David S. Hage

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

An affinity monolith based on silica and containing immobilized human serum albumin (HSA) was developed and evaluated in terms of its binding, efficiency and selectivity in chiral separations. The results were compared with data obtained for the same protein when used as a chiral stationary phase with HPLC-grade silica particles or a monolith based on a copolymer of glycidyl methacrylate (GMA) and ethylene dimethacrylate (EDMA). The surface coverage of HSA in the silica monolith was similar to values obtained with silica particles and a GMA/EDMA monolith. However, the higher surface area of the silica monolith gave a material that contained 1.3-2.2-times more immobilized HSA per unit volume when compared to silica particles or a GMA/EDMA monolith. The retention, efficiency and resolving power of the HSA silica monolith were evaluated using two chiral analytes: d/l-tryptophan and R/S-warfarin. The separation of R- and S-ibuprofen was also considered. The HSA silica monolith gave higher retention and higher or comparable resolution and efficiency when compared with HSA columns that contained silica particles or a GMA/EDMA monolith. The silica monolith also gave lower back pressures and separation impedances than these other materials. It was concluded that silica monoliths can be valuable alternatives to silica particles or GMA/EDMA monoliths when used with immobilized HSA as a chiral stationary phase.

Original languageEnglish (US)
Pages (from-to)820-830
Number of pages11
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume46
Issue number5
DOIs
StatePublished - Apr 14 2008

Fingerprint

Serum Albumin
Silicon Dioxide
Ibuprofen
Optical resolving power
Warfarin
Electric Impedance
Tryptophan
Copolymers
High Pressure Liquid Chromatography
glycidyl methacrylate
ethylene dimethacrylate
Pressure

Keywords

  • Affinity monolith
  • Chiral separation
  • Human serum albumin
  • Schiff base method
  • Silica monolith

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • Clinical Biochemistry

Cite this

Development of an affinity silica monolith containing human serum albumin for chiral separations. / Mallik, Rangan; Hage, David S.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 46, No. 5, 14.04.2008, p. 820-830.

Research output: Contribution to journalArticle

@article{43991c95358e47b1af92edaf0580de62,
title = "Development of an affinity silica monolith containing human serum albumin for chiral separations",
abstract = "An affinity monolith based on silica and containing immobilized human serum albumin (HSA) was developed and evaluated in terms of its binding, efficiency and selectivity in chiral separations. The results were compared with data obtained for the same protein when used as a chiral stationary phase with HPLC-grade silica particles or a monolith based on a copolymer of glycidyl methacrylate (GMA) and ethylene dimethacrylate (EDMA). The surface coverage of HSA in the silica monolith was similar to values obtained with silica particles and a GMA/EDMA monolith. However, the higher surface area of the silica monolith gave a material that contained 1.3-2.2-times more immobilized HSA per unit volume when compared to silica particles or a GMA/EDMA monolith. The retention, efficiency and resolving power of the HSA silica monolith were evaluated using two chiral analytes: d/l-tryptophan and R/S-warfarin. The separation of R- and S-ibuprofen was also considered. The HSA silica monolith gave higher retention and higher or comparable resolution and efficiency when compared with HSA columns that contained silica particles or a GMA/EDMA monolith. The silica monolith also gave lower back pressures and separation impedances than these other materials. It was concluded that silica monoliths can be valuable alternatives to silica particles or GMA/EDMA monoliths when used with immobilized HSA as a chiral stationary phase.",
keywords = "Affinity monolith, Chiral separation, Human serum albumin, Schiff base method, Silica monolith",
author = "Rangan Mallik and Hage, {David S.}",
year = "2008",
month = "4",
day = "14",
doi = "10.1016/j.jpba.2007.03.017",
language = "English (US)",
volume = "46",
pages = "820--830",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Development of an affinity silica monolith containing human serum albumin for chiral separations

AU - Mallik, Rangan

AU - Hage, David S.

PY - 2008/4/14

Y1 - 2008/4/14

N2 - An affinity monolith based on silica and containing immobilized human serum albumin (HSA) was developed and evaluated in terms of its binding, efficiency and selectivity in chiral separations. The results were compared with data obtained for the same protein when used as a chiral stationary phase with HPLC-grade silica particles or a monolith based on a copolymer of glycidyl methacrylate (GMA) and ethylene dimethacrylate (EDMA). The surface coverage of HSA in the silica monolith was similar to values obtained with silica particles and a GMA/EDMA monolith. However, the higher surface area of the silica monolith gave a material that contained 1.3-2.2-times more immobilized HSA per unit volume when compared to silica particles or a GMA/EDMA monolith. The retention, efficiency and resolving power of the HSA silica monolith were evaluated using two chiral analytes: d/l-tryptophan and R/S-warfarin. The separation of R- and S-ibuprofen was also considered. The HSA silica monolith gave higher retention and higher or comparable resolution and efficiency when compared with HSA columns that contained silica particles or a GMA/EDMA monolith. The silica monolith also gave lower back pressures and separation impedances than these other materials. It was concluded that silica monoliths can be valuable alternatives to silica particles or GMA/EDMA monoliths when used with immobilized HSA as a chiral stationary phase.

AB - An affinity monolith based on silica and containing immobilized human serum albumin (HSA) was developed and evaluated in terms of its binding, efficiency and selectivity in chiral separations. The results were compared with data obtained for the same protein when used as a chiral stationary phase with HPLC-grade silica particles or a monolith based on a copolymer of glycidyl methacrylate (GMA) and ethylene dimethacrylate (EDMA). The surface coverage of HSA in the silica monolith was similar to values obtained with silica particles and a GMA/EDMA monolith. However, the higher surface area of the silica monolith gave a material that contained 1.3-2.2-times more immobilized HSA per unit volume when compared to silica particles or a GMA/EDMA monolith. The retention, efficiency and resolving power of the HSA silica monolith were evaluated using two chiral analytes: d/l-tryptophan and R/S-warfarin. The separation of R- and S-ibuprofen was also considered. The HSA silica monolith gave higher retention and higher or comparable resolution and efficiency when compared with HSA columns that contained silica particles or a GMA/EDMA monolith. The silica monolith also gave lower back pressures and separation impedances than these other materials. It was concluded that silica monoliths can be valuable alternatives to silica particles or GMA/EDMA monoliths when used with immobilized HSA as a chiral stationary phase.

KW - Affinity monolith

KW - Chiral separation

KW - Human serum albumin

KW - Schiff base method

KW - Silica monolith

UR - http://www.scopus.com/inward/record.url?scp=40849114582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849114582&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2007.03.017

DO - 10.1016/j.jpba.2007.03.017

M3 - Article

C2 - 17475436

AN - SCOPUS:40849114582

VL - 46

SP - 820

EP - 830

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 5

ER -